[Federal Register: April 17, 2003 (Volume 68, Number 74)] [Notices] [Page 18972] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr17ap03-54] ----------------------------------------------------------------------- DEPARTMENT OF DEFENSE Department of the Army Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Application Concerning Ebola Virion Proteins Expressed From Venezuelan Equine Encephalitis (VEE) Virus Replicons AGENCY: Department of the Army, DoD. ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: In accordance with 37 CFR 404.6 and 404.7, announcement is made of the availability for licensing of U.S. Patent Application No. 09/337,946 entitled ``Ebola Virion Proteins Expressed from Venezuelan Equine Encephalitis (VEE) Virus Replicons,'' filed June 22, 1999. Foreign rights are also available (PCT/US99/14311). The United States Government, as represented by the Secretary of the Army, has rights in this invention. ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, Frederick, MD 21702-5012. FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul Mele, Office of Research & Technology Assessment, (301) 619-6664, both at telefax (301) 619-5034. SUPPLEMENTARY INFORMATION: Using the Ebola GP, NP, VP24, VP30, VP35 and VP40 virion proteins, a method and composition for use in inducing an immune response which is protective against infection with Ebola virus is described. Luz D. Ortiz, Army Federal Register Liaison Officer. [FR Doc. 03-9469 Filed 4-16-03; 8:45 am] BILLING CODE 3710-08-M